HIV/AIDS Clinical Trials

Showing 1261-1280 of 1,802 trials

Human Immune Responses Toward HIV-1 Envelope Antigens

NCT01344941

The primary objectives of this study is to * Define the envelope-specific B-cell and T-cell responses in humans who have received a St. Jude HIV-1 vaccine. * Describe mechanisms of HIV-1 envelope processing and consequent B-cell and T-cell activities.

HIV Infection

St. Jude Children's Research Hospital8 participantsStarted Mar 2010

Memphis, Tennessee, United States

COMPLETEDPhase 4

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

NCT00233883

The purpose of this study is to evaluate the tolerability of a subcutaneous needle-free injection device used to administer Fuzeon, compared with the standard needle/syringe supplied with commercial Fuzeon. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

HIV Infections

Hoffmann-La Roche58 participantsStarted Aug 2005

Long Beach, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +14 more locations

UNKNOWN

Evaluation of an Innovative Tuberculosis Diagnostic Test

NCT02573623

Diagnosis of tuberculosis (TB)in young children is a challenge due to atypical non-specific symptoms, difficulty to expectorate mucus, paucibacillary nature of pulmonary TB and low sensitivity of available diagnostic tools. This project aims at evaluating two innovative immunological methods for diagnosing of active TB among HIV-infected and uninfected children.

TuberculosisHIV

ANRS, Emerging Infectious Diseases300 participantsStarted Jul 2013

Lusaka, Zambia

Human Immune Responses Toward HIV-1 Envelope Antigens

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

Evaluation of an Innovative Tuberculosis Diagnostic Test

Related Searches

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Development of Method of Fructose Identification in Urine to Detect the Viral Infection

Being Responsible for Ourselves HIV Risk Reduction for Black MSM

RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice

Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment

HIV Posterior Cheek Enlargement

Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)